InvestSMART

Synlait Milk Limited (ASX:SM1)

ALERT: Price-sensitive ASX Announcement for SM1
Current share price for SM1 : $0.335 -0.075 (-18.29%)+
Release
23 Mar 2026 7:30AM
Price at Release
$0.410
Full Release
download
Summary
Synlait Milk Limited announced a significant transaction with Abbott concerning the sale of its North Island assets for NZ$307 million, slated for completion on 1 April 2026. This sale is part of a broader recovery strategy amid challenging financial circumstances. The half-year results ending 31 January 2026 reflected multiple headwinds faced by the company, prompting the introduction of a 'Stabilise, Simplify and Scale' recovery roadmap aimed at returning to profitability. The company is focusing on enhancing operational stability and maximizing the potential of its South Island assets, with leadership determined to over-deliver in the coming 12 to 24 months. These developments were communicated to shareholders on 23 March 2026.
Key Points
  • Synlait Milk Limited is in the process of selling its North Island assets to Abbott for approximately NZ$307 million.
  • The company released its half-year results for the six months ended 31 January 2026, highlighting ongoing challenges.
  • Synlait has developed a 'Stabilise, Simplify and Scale' recovery roadmap to improve financial performance.
  • The sale of North Island assets is expected to significantly improve Synlait's balance sheet.
  • Synlait is focusing on operational stability and maximizing its South Island assets for future success.
  • The company acknowledges the disappointment in the current financial results but remains optimistic about long-term recovery.
  • Synlait's leadership expresses determination to over-deliver in the next 12 to 24 months.
  • The half-year results and recovery roadmap were shared with shareholders on 23 March 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.